Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$387K Sell
3,800
-31
-0.8% -$3.48K 0.19% 69
2026
Q1
$416K Sell
3,831
-630
-14% -$72.1K 0.25% 57
2025
Q4
$408K Buy
+4,461
New +$402K 0.24% 57
2025
Q2
Sell
-6,353
Closed -$289K 48
2025
Q1
$289K Sell
6,353
-437
-6% -$20.6K 0.25% 60
2024
Q4
$349K Buy
+6,790
New +$370K 0.31% 53

Other funds holding CCJ

SharpePoint's CCJ Position: Q2 2026 in Review

SharpePoint reduced its Cameco (CCJ) stake by 0.81% in Q2 2026, selling an estimated $3.48K and leaving 3,800 shares worth $387K. The position accounts for 0.19% of the portfolio, ranked #69.

SharpePoint first reported a position in CCJ in Q4 2024 and has held it in 5 quarters since. The position peaked at $416K in Q1 2026. 1,036 funds tracked by Wall St. Rank hold CCJ as of Q2 2026.

  • SharpePoint held 3,800 shares of Cameco worth $387K as of Q2 2026.
  • SharpePoint sold 31 Cameco shares in Q2 2026, an estimated $3.48K.
  • Cameco made up 0.19% of SharpePoint's portfolio in Q2 2026, its #69 holding.
  • SharpePoint first reported a position in Cameco in Q4 2024 and has held it in 5 quarters since.
  • SharpePoint's Cameco position peaked at $416K in Q1 2026.
  • 1,036 funds tracked by Wall St. Rank held Cameco as of Q2 2026.

Based on SharpePoint's 13F filing for Q2 2026, filed 29 Jul 2026.